• Policy & Insight

Precision prevention: how to take the next step in preventing cancer

It's becoming possible to prevent more cancers by targeting the earliest changes that can lead to cancer in people at high risk. But precision prevention needs support to reach its potential. It's becoming possible to prevent more cancers by targeting the earliest changes that can lead to cancer in people at high risk. But precision prevention needs support to reach its potential.

5 June 2026

• For Researchers

Unlocking a new era for cancer prevention research

Precision prevention research is shifting the dial on cancer prevention - but barriers are holding the UK back. Seren Limb digs into some solutions... Precision prevention research is shifting the dial on cancer prevention - but barriers are holding the UK back. Seren Limb digs into some solutions...

2 June 2026

• Health & Medicine

UK NSC recommends targeted prostate cancer screening

The UK NSC has recommended targeted prostate cancer screening for men with a BRCA2 gene change and a family history of linked cancers. It's an important step towards more personalised, risk‑based screening, and could help detect prostate cancer earlier in the people with the highest risk. The UK NSC has recommended targeted prostate cancer screening for men with a BRCA2 gene change and a family history of linked cancers. It's an important step towards more personalised, risk‑based screening, and could help detect prostate cancer earlier in the people with the highest risk.

28 May 2026

• Charity News

Beyond the research: 6 ways we’ve turned evidence into impact

Research doesn’t improve cancer outcomes on its own. Our policy, campaigning and information are crucial for supporting longer, better lives. Research doesn’t improve cancer outcomes on its own. Our policy, campaigning and information are crucial for supporting longer, better lives.

25 May 2026

• For Researchers

The gatekeeper and the invader – H.pylori and the development of stomach cancer

Gastric adenocarcinoma is strongly linked to H.pylori infection, yet only 1% of people infected develop the disease. So, what’s going on? Gastric adenocarcinoma is strongly linked to H.pylori infection, yet only 1% of people infected develop the disease. So, what’s going on?

18 May 2026

• For Researchers

Let there be light - a new route to precision diagnosis

Histopathology represents the current gold standard for cancer diagnostics – but is there a better way? For Mads Bergholt, biophotonics holds the answer… Histopathology represents the current gold standard for cancer diagnostics – but is there a better way? For Mads Bergholt, biophotonics holds the answer…

6 May 2026

• For Researchers

Philosophically speaking – finding a path to the big picture

How can we get from specialist knowledge to big picture thinking for cancer research? James DiFrisco takes us through the power of having a wide-angle lens…     How can we get from specialist knowledge to big picture thinking for cancer research? James DiFrisco takes us through the power of having a wide-angle lens…    

29 April 2026

• Health & Medicine
• Policy & Insight

Cancer in the UK: what's needed as cases exceed 400,000 a year

Every 80 seconds, someone in the UK is diagnosed with cancer. Our Cancer in the UK report explains how to take on that challenge. Every 80 seconds, someone in the UK is diagnosed with cancer. Our Cancer in the UK report explains how to take on that challenge.

23 April 2026